Literature DB >> 24750185

Induced nitric oxide synthetase and peroxiredoxin expression in intramucosal poorly differentiated gastric cancer of young patients.

Minako Hirahashi1, Yutaka Koga, Reiko Kumagai, Shinichi Aishima, Kenichi Taguchi, Yoshinao Oda.   

Abstract

To investigate the relationship between oxidative stress and gastric carcinogenesis of poorly differentiated adenocarcinoma in young patients, we analyzed the surgically resected specimens of 22 young patients (21-30 years) and 29 older patients (41-72 years) with intramucosal gastric cancer of the poorly differentiated type. We used immunohistochemical staining to evaluate the expression of 8-hydroxydeoxyguanosine (8OHdG), induced nitric oxide synthetase (iNOS), and antioxidant enzymes (thioredoxin [TRX] and peroxiredoxin [PRDX1, 2 and 3]). We assessed these proteins in the cancer, noncancerous gastric foveolar epithelium and noncancerous mucosal neck. In both the young and older patient groups, the 8OHdG and TRX expressions were gradually increased in cancer cells compared with the noncancerous foveolar epithelial cells and the noncancerous mucosal neck cells (P < 0.001). Although the iNOS and PRDXs expressions were increased in the noncancerous mucosal neck cells compared with the noncancerous foveolar epithelial cells, regardless of age (P < 0.001), the iNOS and PRDX2 expression in the cancer cells were significantly reduced in the young patients compared with the older patients (P < 0.001, P < 0.05). In conclusion, the reduced expression of iNOS or PRDX2 may play an important role in the carcinogenesis of gastric cancer associated with Helicobacter pylori-induced chronic active gastritis in young patients.
© 2014 The Authors. Pathology International © 2014 Japanese Society of Pathology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  8OHdG; gastric cancer; iNOS; peroxiredoxin; thioredoxin

Mesh:

Substances:

Year:  2014        PMID: 24750185     DOI: 10.1111/pin.12152

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  7 in total

Review 1.  The Immune Battle against Helicobacter pylori Infection: NO Offense.

Authors:  Alain P Gobert; Keith T Wilson
Journal:  Trends Microbiol       Date:  2016-02-22       Impact factor: 17.079

2.  Integrated analysis identified an intestinal-like and a diffuse-like gene sets that predict gastric cancer outcome.

Authors:  Cheng Zhang; Li Min; Jiafei Liu; Wei Tian; Yong Han; Like Qu; Chengchao Shou
Journal:  Tumour Biol       Date:  2016-11-17

Review 3.  Human and Helicobacter pylori Interactions Determine the Outcome of Gastric Diseases.

Authors:  Alain P Gobert; Keith T Wilson
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

Review 4.  Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review).

Authors:  Abbas Salihi; Mohammed A Al-Naqshabandi; Zhikal Omar Khudhur; Zjwan Housein; Harmand A Hama; Ramyar M Abdullah; Bashdar Mahmud Hussen; Twana Alkasalias
Journal:  Mol Med Rep       Date:  2022-05-26       Impact factor: 3.423

5.  Nitric oxide inhibits autophagy and promotes apoptosis in hepatocellular carcinoma.

Authors:  XiaoGang Zhang; Li Jin; Zhen Tian; Jing Wang; Yuan Yang; JinFeng Liu; Yi Chen; ChunHua Hu; TianYan Chen; YingRen Zhao; YingLi He
Journal:  Cancer Sci       Date:  2019-02-16       Impact factor: 6.716

6.  Formulation, optimization and characterization of allantoin-loaded chitosan nanoparticles to alleviate ethanol-induced gastric ulcer: in-vitro and in-vivo studies.

Authors:  Reham Mokhtar Aman; Randa A Zaghloul; Marwa S El-Dahhan
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

7.  Identification and Comparison of Differentiation-Related Proteins in Hepatocellular Carcinoma Tissues by Proteomics.

Authors:  Sheng Zhao; Gang Su; Wenke Yang; Ping Yue; Bing Bai; Yanyan Lin; Jinduo Zhang; Yongjiang Ba; Zhiwen Luo; Xiaoming Liu; Lili Zhao; Yi Xie; Yaowei Xu; Shuo Li; Wenbo Meng; Xiaodong Xie; Xun Li
Journal:  Technol Cancer Res Treat       Date:  2017-09-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.